Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The terminal D-alanyl-D-alanine (D-Ala-D-Ala) motif is a critical structural component of the peptidoglycan precursors in the cell walls of Gram-positive bacteria. It serves as the substrate for transpeptidase enzymes, also known as penicillin-binding proteins, which catalyze the cross-linking of peptidoglycan chains to provide mechanical strength to the bacterial cell wall (StatPearls, 2023). This motif is the primary target for glycopeptide antibiotics, such as vancomycin and teicoplanin, which bind to the dipeptide via five hydrogen bonds (Nature Reviews Microbiology, 2017). By sequestering the D-Ala-D-Ala terminus, these drugs sterically hinder the enzymes responsible for cell wall polymerization and cross-linking, leading to bacterial cell lysis and death. Resistance to these antibiotics often involves the modification of this target, where the terminal D-alanine is replaced by D-lactate or D-serine, significantly reducing the binding affinity of the drug (Journal of Biological Chemistry, 2014). Understanding this motif is essential for the development of next-generation antibiotics designed to overcome bacterial resistance mechanisms.
Glycopeptide antibiotics bind to the D-alanyl-D-alanine terminus of peptidoglycan precursors through hydrogen bonding, sterically inhibiting the transglycosylation and transpeptidation steps required for cell wall assembly.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Terminal D-alanyl-D-alanine motif of peptidoglycan precursors (D-Ala-D-Ala).